This inventor holds 2 USPTO granted patents. Top assignees: Dongbu Hannong Chemical Co., Ltd., Schaeffler Technologies Ag & Co .Kg. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 12 
1 out of 3,795 
Years Active: 2007-2008
Title: Innovations of Dong Ha Lee in Pharmaceutical Chemistry
Introduction
Dong Ha Lee is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on benzopyran derivatives. With a total of 2 patents, his inventions focus on protecting tissues from ischemia-reperfusion injuries.
Latest Patents
Dong Ha Lee's latest patents include two significant innovations. The first patent involves benzopyran derivatives substituted with a thioxobenzoxazole derivative, along with their pharmaceutically acceptable salts and preparations. This invention aims to provide a pharmaceutical composition that effectively protects the heart from ischemia-reperfusion both in vivo and in vitro. The derivatives can be used for the protection of various tissues, including the heart, nervous cells, brain, and retinal cells, as well as for treating diseases caused by ischemia-reperfusion.
The second patent focuses on benzopyran derivatives substituted with a benzimidazole derivative. Similar to the first, this invention also includes pharmaceutically acceptable salts and preparation methods. The derivatives are designed to protect the heart from ischemia-reperfusion without the side effects associated with vasodilation. This innovation can also be utilized for the protection of various tissues and for treating ischemia-reperfusion-related diseases.
Career Highlights
Throughout his career, Dong Ha Lee has worked with reputable companies such as Schaeffler Technologies AG & Co. KG and Dongbu Hannong Chemical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Hong Seok Lim and Sun Ok Kim. Their collaborative efforts have likely played a role in advancing their shared research interests.
Conclusion
Dong Ha Lee's contributions to pharmaceutical chemistry through his innovative patents demonstrate his commitment to advancing medical science. His work on benzopyran derivatives showcases the potential for developing effective treatments for ischemia-reperfusion injuries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile